Recent Finacing
Recent Raise
OncoPep develops peptide-adjuvant immunotherapeutics, advancing PVX-410—a multi-peptide therapeutic vaccine for smoldering multiple myeloma and TNBC—through Phase 1/2a dose‑escalation trials including lenalidomide combinations.
